BACKGROUND AND PURPOSE: Disease activity in normal-appearing white matter (NAWM) in multiple sclerosis (MS) has been demonstrated in vivo with T1 relaxation time measurements. We aimed to investigate the spatial distribution of T1 increases in MS NAWM without a priori selection of specific regions. METHODS: Whole-brain quantitative T1 maps were measured in 67 patients with one of the 3 main clinical types of MS (13 primary progressive [PP], 36 relapsing-remitting [RR], and 18 secondary progressive [SP]) and in 23 healthy control subjects. After registration to standard space and segmentation of NAWM, the maps were analyzed by using voxel-based analyses with a cluster-based corrected P threshold of .05. RESULTS: Group mean T1 relaxation times throughout NAWM increased when going from control subjects to PP to RR to SP MS. In the RR and SP MS groups, the T1 increases compared with control subjects were significant throughout the NAWM, without apparent preference for specific brain regions. In RR MS, 16% of NAWM voxels displayed a significant increase in T1 compared with control subjects, and in SP, this fraction was 49%. The comparison between RR MS and the subsequent phase SP MS revealed that, in these patients, disease progression occurs throughout the NAWM. In patients with PP MS, the spatial extent of significant T1 increases is limited. There were no correlations with clinical disability scales or brain volume in a substantial fraction of voxels. CONCLUSION: This study demonstrates that in patients with RR MS and SP MS, NAWM disease processes have no regional preferences but can occur throughout the brain.
BACKGROUND AND PURPOSE: Disease activity in normal-appearing white matter (NAWM) in multiple sclerosis (MS) has been demonstrated in vivo with T1 relaxation time measurements. We aimed to investigate the spatial distribution of T1 increases in MS NAWM without a priori selection of specific regions. METHODS: Whole-brain quantitative T1 maps were measured in 67 patients with one of the 3 main clinical types of MS (13 primary progressive [PP], 36 relapsing-remitting [RR], and 18 secondary progressive [SP]) and in 23 healthy control subjects. After registration to standard space and segmentation of NAWM, the maps were analyzed by using voxel-based analyses with a cluster-based corrected P threshold of .05. RESULTS: Group mean T1 relaxation times throughout NAWM increased when going from control subjects to PP to RR to SP MS. In the RR and SP MS groups, the T1 increases compared with control subjects were significant throughout the NAWM, without apparent preference for specific brain regions. In RR MS, 16% of NAWM voxels displayed a significant increase in T1 compared with control subjects, and in SP, this fraction was 49%. The comparison between RR MS and the subsequent phase SP MS revealed that, in these patients, disease progression occurs throughout the NAWM. In patients with PP MS, the spatial extent of significant T1 increases is limited. There were no correlations with clinical disability scales or brain volume in a substantial fraction of voxels. CONCLUSION: This study demonstrates that in patients with RR MS and SP MS, NAWM disease processes have no regional preferences but can occur throughout the brain.
Authors: Stephen M Smith; Yongyue Zhang; Mark Jenkinson; Jacqueline Chen; P M Matthews; Antonio Federico; Nicola De Stefano Journal: Neuroimage Date: 2002-09 Impact factor: 6.556
Authors: M Filippi; M Inglese; M Rovaris; M P Sormani; P Horsfield; P G Iannucci; B Colombo; G Comi Journal: Neurology Date: 2000-10-10 Impact factor: 9.910
Authors: O Ciccarelli; D J Werring; C A Wheeler-Kingshott; G J Barker; G J Parker; A J Thompson; D H Miller Journal: Neurology Date: 2001-04-10 Impact factor: 9.910
Authors: Colette M Griffin; Declan T Chard; Geoff J M Parker; Gareth J Barker; Alan J Thompson; David H Miller Journal: J Neurol Date: 2002-02 Impact factor: 4.849
Authors: Daniel L Schwartz; Ian Tagge; Katherine Powers; Sinyeob Ahn; Rohit Bakshi; Peter A Calabresi; R Todd Constable; John Grinstead; Roland G Henry; Govind Nair; Nico Papinutto; Daniel Pelletier; Russell Shinohara; Jiwon Oh; Daniel S Reich; Nancy L Sicotte; William D Rooney Journal: J Magn Reson Imaging Date: 2019-01-16 Impact factor: 4.813
Authors: Mike P Wattjes; Michael Harzheim; Götz G Lutterbey; Manuela Bogdanow; Stephan Schmidt; Hans H Schild; Frank Träber Journal: Neuroradiology Date: 2007-11-03 Impact factor: 2.804
Authors: Mike P Wattjes; Michael Harzheim; Götz G Lutterbey; Manuela Bogdanow; Hans H Schild; Frank Träber Journal: J Neurol Date: 2007-12-20 Impact factor: 4.849
Authors: Benjamin S Aribisala; Natalie A Royle; Susana Muñoz Maniega; Maria C Valdés Hernández; Catherine Murray; Lars Penke; Alan Gow; John M Starr; Mark E Bastin; Ian J Deary; Joanna M Wardlaw Journal: Cortex Date: 2013-12-31 Impact factor: 4.027
Authors: Sen Ma; Nan Wang; Zhaoyang Fan; Marwa Kaisey; Nancy L Sicotte; Anthony G Christodoulou; Debiao Li Journal: Magn Reson Med Date: 2020-10-26 Impact factor: 4.668
Authors: Henrik Lund; Martin Krakauer; Arnold Skimminge; Finn Sellebjerg; Ellen Garde; Hartwig R Siebner; Olaf B Paulson; Dan Hesse; Lars G Hanson Journal: PLoS One Date: 2013-02-18 Impact factor: 3.240